Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Ecdysone receptor–retinoid X receptor heterodimer complex** (EcR–RXR) is a specialized nuclear receptor complex found in arthropods (insects and crustaceans). It is composed of the ecdysone receptor (EcR), which binds the steroid hormone ecdysone or its analogues (ecdysteroids), and the retinoid X receptor (RXR; known as ultraspiracle/USP in insects)[1][4][5]. Upon binding ecdysteroids, the EcR–RXR heterodimer acts as a ligand-dependent transcription factor, binding to specific DNA elements (often IR-1 type response elements) to regulate gene expression necessary for molting, metamorphosis, and other developmental processes[1][2][6][7]. This receptor complex is crucial for normal development in insects and crustaceans, controls the expression of many downstream genes, and is the molecular target for several insecticidal compounds used in pest management[5][7]. RXR (or USP) serves as a universal heterodimer partner within the nuclear receptor superfamily, influencing the receptor’s DNA-binding specificity and function[5]. In insects, the complex is the canonical receptor for ecdysone signaling, and in crustaceans, RXR fulfills a similar role as in vertebrates[4][6]. Key physiological processes include regulation of molting, reproduction, embryogenesis, and tissue remodeling[4][6]. The molecular mechanism involves hormone-driven dimerization, DNA binding, and modulation of target gene transcription[1][2][5]. Species specificity in ligand binding (ecdysteroids, retinoids) and protein structure is notable—RXR/USP in insects does not bind mammalian retinoids like 9-cis-retinoic acid, while RXR in other arthropods might[6]. This unique biology underlies the complex's value as a highly selective target for insecticides, though resistance and non-target impacts remain challenges[7].
Ligand (ecdysteroid)-dependent transcriptional activation of target genes through DNA binding. Induction (or repression) of gene expression via response elements upon heterodimer formation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ecdysone receptor–retinoid X receptor heterodimer complex (EcR–RXR heterodimer).